In the current study, compared to that cohort, the frequency of aCL IgA was lower in both the APS and aPL (+) SLE groups, while the frequency of aβ2GPI IgA was similar in the APS group, but much higher in the aPL (+) SLE group. The gene discussed is CD79A; the disease is autoimmune polyendocrinopathy.